Castiella A, Zapata E, Zubiaurre L, Iribarren A, Alústiza JM, Otazua P, Salvador E, Emparanza JI

Language: English
References: 23
Page: 540-544
PDF size: 145.54 Kb.

ABSTRACT

Background & aims. Hyperferritinemia (HF) is frequently present in patients with metabolic syndrome (MS). MS associated with HF is named dysmetabolic hyperferritinemia (DH). There are some publications that propose that DH is associated with a raised liver iron concentration (LIC). We studied the LIC in patients referred for HF to a secondary hospital to determine if there are differences between patients with or without MS. Material and methods. We conducted a prospective study of 132 consecutive patients with HF from January to December 2010. The MS was defined by the International Diabetes Federation criteria (2005). LIC was determined by Magnetic resonance imaging (MRI). Results. The number of patients for which there was enough data to determine MS was 97, out of which 54 had MS and 43 had no MS (NMS). In 54/97 patients, MRI for LIC determination was performed. From the MS group, 44 were men (27 underwent MRI) and 10 women (9 MRI). The mean LIC was 27.83 ± 20.90 µmol/g for the MS group. In the NMS group, 36 were men (13 MRI), and 7 women (5 MRI). In 18 patients from the NMS group, LIC was determined by MRI. The mean LIC was 33.16 ± 19.61 µmol/g in the NMS group. We compared the mean values of LIC from both groups (MS vs. NMS) and no significant differences were found (p = 0.067). Conclusion. Patients with DH present a mean LIC within normal values and their values do not differ from those of patients with HF but without MS.

REFERENCES

1. Alkerwi A, Donneau AF, Sauvageor N, Lair ML, Scheen A, Albert A, Guillaume Ml. Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study. BMC Public Health 2011; 11: 4.

2. McCullough AJ. The epidemiology of the metabolic syndrome in the USA. J Dig Dis 2011; 12: 333-40.

3. Chen LY, Chang SD, Sreenivasan GM, Tsang PW, Broady RC, Li CH, Zypchen LN. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin. Ann Hematol 2011; 90: 139-43.

4. Brudevold R, Hole T, Hammerstrom J. Hyperferritinemia is associated with insuline resistence and fatty liver in patients without iron overload. PLoS One 2008; 3: e347.

5. Castiella A, Alústiza JM, Zapata E, Emparanza JI, Otazua P, Zubiaurre L, Aguirre A. Mild iron overload in dysmetabolic hyperferritinemia: MRI may overestimate the liver iron concentration values. Ann Hematol 2012; 91: 961.

6. Castiella A, Zapata E, Zubiaurre L, Alustiza JM, De Juan MD, Iribarren A, Emparanza JI, et al. Impact of H63D mutations, magnetic resonance and metabolic syndrome among outpatient referrals for elevated serum ferritin in the Basque Country. Ann Hepatol 2015; 14: 333-9.

7. Alustiza JM, Artetxe J, Castiella A, Aguirre C, Emparanza JI, Otazua P, Garcia-Bengoechea M, et al. MR quantification of hepatic iron concentration. Radiology 2004; 230: 479-84.

8. Licata A, Nebbia ME, Cabibbo G, Lo Iacono G, Barbaria F, Brucato V, Alessi N, et al. Hyperferritinemia is a risk factor for steatosis in chronic liver disease. World J Gastroenterol 2009; 15: 2132-8.

9. Alústiza JM, Castiella A. Liver fat and iron at in-phase and opposed-phase MR imaging. Radiology 2008; 246: 641.

10. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new world wide definition. Lancet 2005; 366: 1059-62.

11. Mendler MH, Turlin B, Moirand R, Jouanolle A, Sapey T, Guyader D, Le Gall, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999; 117: 1155-63.

12. Riva A, Trombini P, Mariani R, Salvioni A, Coletti S, Bonfadini S, Paolini V, et al. Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome. World J Gastroenterol 2008; 14: 4745-52.

13. Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, et al. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 2001; 96: 2448-55.

14. Dongiovanni P, Fracanzani AL, Fargion S, Valenti L. Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target. J Hepatol 2011; 55: 920-32.

15. Jézéquel C, Lainé F, Laviolle B, Kiani A, Bardou-Jacquet E, Deugnier Y. Both hepatic and body iron stores are increased in dysmetabolic iron overload syndrome. A casecontrol study. PLoS ONE 2015; 10: e0128530.

16. Valenti L, Fracanzani AL, Dongiovanni P, Rovida S, Rametta R, Fatta E, Pulixi EA, et al. A randomized trial of iron depletion in patients with non-alcoholic fatty liver disease and hyperferritinemia. World J Gastroenterol 2014; 20: 3002-10.

17. Adams LA, Crawford DH, Stuart K, House MJ, St Pierre TG, Webb M, Ching HL, et al. The impact of phlebotomy in non-alcoholic fatty liver disease: A prospective, randomized, controlled trial. Hepatology 2015; 61: 1555-64.

18. Brissot P, de Bels F. Current approaches to the manegement of hemochromatosis. Hematology Am Soc Hematol Educ Program 2006: 36-41.

19. Bozzini C, Girelli D, Olivieri O, Martinelli N, Bassi A, De Matteis G, Tenuti I, et al. Prevalence of body iron excess in the metabolic syndrome. Diab Care 2005; 28: 2061-3.

20. Waeber G, Vollenweider P, Maeques-Vidal PM. Dysmetabolic hyperferritinemia: a new target for treatment? Rev Med Suisse 2013; 9: 2002-7.

21. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, Deugnier Y. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357-62.

22. Castiella A, Alustiza JM, Emparanza JI, Zapata EM, Costero B, Diez MI. Liver iron concentration quantification by MRI: are recommended protocols accurate enough for clinical practice? Eur Radiol 2011; 21: 137-41.

23. Freixenet N, Vilardell C, Llauradó G, Giménez-Palop O, Berlanga E, Gutiérrez C, Caixŕs A, et al. Men with hyperferritinemia and diabetes in the Mediterranean area do not have a higher iron overload than those without diabetes. Diabetes Res Clin Pract 2011; 91: e33-e36.